Tusheel 30 Laminas Bucodispersable

Expectorant. Ivy exerts expectorant and antispasmodic effects, probably due to its content in saponic heterosides (hederaglycosides). The mechanism by which these act is unknown.

- The use of mucolytics and expectorants in children under 2 years of age is contraindicated as a result of the risk of bronchial obstruction.

- Persistent or recurrent continuous cough in children 2 to 4 years of age should be diagnosed by the doctor before starting treatment.

- Concomitant use with other antitussives such as codeine or dextrometorphane without prior medical consultation is not recommended.

- Drink plenty of water during treatment.

- Do not use antitussives containing codeine or dextrometorphane during ivy use.

- Consult your doctor and/or pharmacist if symptoms get worse or not improve within 5 days, or if it appears

dyspnoea, fever, headache or purulent sputums.

Animal safety: no data available.

Human safety :adequate and well-controlled human studies are not available. Administration is only accepted if there are no safer therapeutic alternatives, and the benefits outweigh the potential risks. It is not recommended for use.

Effects on fertility: no specific studies have been conducted on its effects on fertility.

Plant-based medicine used as an expectorant for [PRODUCTIVE TOS] in adults, adolescents and children over 2 years of age.

They haven't been described.

However, caution is recommended:

- Combination ofntitusives containing codeine, dextrometorphane or ivy extracts due to risk of bronchial obstruction and the appearance of neurotoxic effects. Avoid association especially in children.

- Anticholinergics (atropine, antihistamines, tricyclic antidepressants, antiparkinsonians, neuroleptics, IMAO). They could oppose the ivy effect.

It is not known whether it is excreted with milk, and the consequences it could have for the infant. It is recommended to stop breastfeeding or avoid administration.

The use of mucolytics in children under 2 years of age has been linked to the onset of bronchial obstruction, as a result of increased production and fluidization of bronchial secretion and insufficient bronchial drainage. Therefore, the use of mucolytics in these children is contraindicated.

In older children, the pharmaceutical form and dose should be adapted to the child's age(see Posology).

In the case of syrups, shake the bottle well before each intake

It is recommended to drink a glass of water after each dose and drink plenty of water during treatment.

Food administration: can be taken with or without food.

"Tushethe Orodispersible Movies"

- Adults, elderly patients and adolescents over 12 years of age

Dosage: an orodispersible film 3 times a day (corresponds to a daily dose of 48 mg ivy leaf extract).

- Children from 6 years to 12 years of age

Dosage: an orodispersible film 3 times a day (corresponds to a daily dose of 48 mg ivy leaf extract).

- Children between 2 and 5 years of age

Dosage: an orodispersible film 2 times a day (corresponds to a daily dose of 32 mg ivy leaf extract).

- Children under 2 years old: contraindicated

Adverse reactions are described according to each frequency interval, considered very common (>10%), common (1-10%), uncommon (0.1-1%), rare (0.01-0.1%), very rare (<0.01%) or of unknown frequency (cannot be estimated from the available data).

- Digestives: frequent [NAUSEAS], [VOMITOS], [DIARREA].

- Allergic: uncommon [HYPERSENSITIVITY REACTIONS], with [URTICARIA], [EXANTEMATIC ERUPTIONS] or [DYSPNOEA].

Symptoms: in case of overdose you would expect an improvement of adverse reactions, especially of a digestive nature (nausea, vomiting, diarrhea), and the appearance of agitation.

Treatment: symptomatic.